Featured Articles

  1. How AI Redefines The Functional Service Provider Opportunity In Medical Affairs 4/7/2025

    Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

  2. Biopharma Should Focus On Product Iteration Over Product Launches 4/4/2025

    Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps that slow down adoption and stall growth, explains Jessica Meng.

  3. Breaking Barriers: From Gendered Perceptions To Inclusive Leadership 4/2/2025

    Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are recognized as strengths, explains Laryssa Wozniak.

  4. Risk Management Planning: Be Prepared When Disaster Strikes 4/1/2025

    Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more.

  5. Navigating AI's Impact On Life Sciences And Patent Law 3/26/2025

    AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

  6. How To Get Ready For The Talent Migration Between Pharma And Biotech 3/25/2025

    A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in Big Pharma and biotech culture and expectations to be successful.

  7. Resetting The Immune System For Lasting Remission 3/19/2025

    Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and inflammatory conditions, using novel targets and improved modalities.

  8. Testing Federal Healthcare Laws: Risks In Genetic-Testing Programs 3/13/2025

    Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly. Experts at Morrison Foerster share best practices for compliance.

  9. Pharma's Guide To Making Health Communications Land Well 3/11/2025

    New treatment paradigms are making biopharma industry stakeholder communications more ambitious and complex. But they must also be credible and consumable, writes Michelle Bridenbaker.

  10. AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility 3/4/2025

    Given the near-constant technological advancements in AI, potential AI policy updates, and regulatory changes, flexible AI systems are necessary for life science organizations to keep pace with change.